Keyphrases
Lung Cancer Treatment
100%
Cardiotoxicity
100%
Non-small Cell Lung Cancer (NSCLC)
100%
Anticancer Drugs
55%
Prospero
22%
Cardiovascular Disease
22%
Lack of Information
11%
Cardiac Failure
11%
Scopus
11%
Arrhythmia
11%
Coronary Artery Disease
11%
Cardiovascular Events
11%
Initial Treatment
11%
PubMed
11%
Patient Treatment
11%
Cancer Survivors
11%
Bradycardia
11%
Death Rate
11%
Hypertension
11%
Heart Failure
11%
Web of Science
11%
Treatment Duration
11%
Ischemia
11%
Radiotherapy
11%
18 Years Old
11%
Atrial Fibrillation
11%
Fatality
11%
Left Ventricular Dysfunction
11%
Drug Class
11%
Tachycardia
11%
Improved Detection
11%
Heart Structure
11%
Bevacizumab
11%
Palpation
11%
Cisplatin
11%
European Union
11%
Detection Method
11%
Rapid Development
11%
Heart Function
11%
Long-term Morbidity
11%
Crizotinib
11%
Cancer Therapy
11%
Search Terms
11%
Cochrane Library
11%
Cancer Treatment
11%
Gemcitabine
11%
Cardiac Arrest
11%
Paclitaxel
11%
Carboplatin
11%
Docetaxel
11%
Data Extraction
11%
Myocardial Infarction
11%
Cardiovascular Adverse Events
11%
National Cancer Institute
11%
Treatment-related
11%
Clinical Trial Registry
11%
In Cancer
11%
Cardiac Monitoring
11%
Erlotinib
11%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Cardiotoxicity
100%
Malignant Neoplasm
55%
Anticarcinogen
55%
Cardiovascular Disease
22%
Congestive Heart Failure
22%
Heart Left Ventricle Failure
11%
Heart Arrhythmia
11%
Mortality Rate
11%
Docetaxel
11%
Ischemia
11%
Heart Infarction
11%
Paclitaxel
11%
Carboplatin
11%
Heart Palpitation
11%
Clinical Trial
11%
Fatality
11%
Coronary Artery Disease
11%
Adverse Event
11%
Heart Arrest
11%
Bevacizumab
11%
Atrial Fibrillation
11%
Gemcitabine
11%
Crizotinib
11%
Cisplatin
11%
Tachycardia
11%
Erlotinib
11%